Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3416
+0.0017 (0.50%)
At close: May 12, 2025, 4:00 PM
0.3580
+0.0164 (4.80%)
After-hours: May 12, 2025, 7:24 PM EDT
Co-Diagnostics Employees
Co-Diagnostics had 132 employees as of December 31, 2024. The number of employees decreased by 23 or -14.84% compared to the previous year.
Employees
132
Change (1Y)
-23
Growth (1Y)
-14.84%
Revenue / Employee
$26,497
Profits / Employee
-$271,668
Market Cap
11.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CODX News
- 3 days ago - Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 13 days ago - Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewsWire
- 6 weeks ago - Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - PRNewsWire
- 2 months ago - Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - PRNewsWire
- 2 months ago - Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PRNewsWire
- 2 months ago - Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Benzinga